BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, Christodoulides T, Dudley R, Chapman N, Callcott P. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet. 2014;383:1395-1403. [PMID: 24508320 DOI: 10.1016/s0140-6736(13)62246-1] [Cited by in Crossref: 145] [Cited by in F6Publishing: 44] [Article Influence: 18.1] [Reference Citation Analysis]
Number Citing Articles
1 Jeppesen UN, Due AS, Mariegaard L, Pinkham A, Vos M, Veling W, Nordentoft M, Glenthøj LB. Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial. Trials 2022;23:658. [PMID: 35971137 DOI: 10.1186/s13063-022-06614-0] [Reference Citation Analysis]
2 Kéri S. Postdiction in Visual Awareness in Schizophrenia. Behav Sci (Basel) 2022;12:198. [PMID: 35735408 DOI: 10.3390/bs12060198] [Reference Citation Analysis]
3 Peters E, Hardy A, Dudley R, Varese F, Greenwood K, Steel C, Emsley R, Keen N, Bowe S, Swan S, Underwood R, Longden E, Byford S, Potts L, Heslin M, Grey N, Turkington D, Fowler D, Kuipers E, Morrison A. Multisite randomised controlled trial of trauma-focused cognitive behaviour therapy for psychosis to reduce post-traumatic stress symptoms in people with co-morbid post-traumatic stress disorder and psychosis, compared to treatment as usual: study protocol for the STAR (Study of Trauma And Recovery) trial. Trials 2022;23:429. [PMID: 35606886 DOI: 10.1186/s13063-022-06215-x] [Reference Citation Analysis]
4 Read J. How important are informed consent, informed choice, and patient-doctor relationships, when prescribing antipsychotic medication? J Ment Health 2022;:1-9. [PMID: 35536145 DOI: 10.1080/09638237.2022.2069708] [Reference Citation Analysis]
5 Jauhar S, Lawrie SM. What is the evidence for antipsychotic medication and alternative psychosocial interventions for people with acute, non-affective psychosis? The Lancet Psychiatry 2022. [DOI: 10.1016/s2215-0366(21)00293-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Cooper RE, Mason JP, Calton T, Richardson J, Moncrieff J. Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia. Psychosis 2021;13:276-85. [DOI: 10.1080/17522439.2021.1930119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Morrison AP, Pyle M, Byrne R, Broome M, Freeman D, Johns L, James A, Husain N, Whale R, MacLennan G, Norrie J, Hudson J, Peters S, Davies L, Bowe S, Smith J, Shiers D, Joyce E, Jones W, Hollis C, Maughan D. Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT. Health Technol Assess 2021;25:1-124. [PMID: 33496261 DOI: 10.3310/hta25040] [Reference Citation Analysis]
8 Grossi LM, Cabeldue M, Brereton A. Cognitive Behavior Therapy for Psychosis (CBT-p) as an Adjunct to Competency Restoration. Journal of Forensic Psychology Research and Practice. [DOI: 10.1080/24732850.2021.1877022] [Reference Citation Analysis]
9 Larijani B, Parhizkar Roudsari P, Hadavandkhani M, Alavi-Moghadam S, Rezaei-Tavirani M, Goodarzi P, Sayahpour FA, Mohamadi-Jahani F, Arjmand B. Stem cell-based models and therapies: a key approach into schizophrenia treatment. Cell Tissue Bank 2021;22:207-23. [PMID: 33387152 DOI: 10.1007/s10561-020-09888-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Jauhar S, Laws KR, Young AH. Mindfulness-based cognitive therapy and depression relapse-evaluating evidence through a meta-analytic lens may indicate myopia. Acta Psychiatr Scand 2021;143:3-5. [PMID: 33423271 DOI: 10.1111/acps.13270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Moritz S, Klein JP, Lysaker PH, Mehl S. Metacognitive and cognitive-behavioral interventions for psychosis: new developments
. Dialogues Clin Neurosci 2019;21:309-17. [PMID: 31749655 DOI: 10.31887/DCNS.2019.21.3/smoritz] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
12 Maas DA, Eijsink VD, Spoelder M, van Hulten JA, De Weerd P, Homberg JR, Vallès A, Nait-Oumesmar B, Martens GJM. Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia. Nat Commun 2020;11:2329. [PMID: 32393757 DOI: 10.1038/s41467-020-16218-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
13 Temesgen WA, Chien WT, Valimaki MA, Bressington D. Predictors of subjective recovery from recent-onset psychosis in a developing country: a mixed-methods study. Soc Psychiatry Psychiatr Epidemiol 2020;55:1187-99. [DOI: 10.1007/s00127-020-01853-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Turner DT, Burger S, Smit F, Valmaggia LR, van der Gaag M. What Constitutes Sufficient Evidence for Case Formulation-Driven CBT for Psychosis? Cumulative Meta-analysis of the Effect on Hallucinations and Delusions. Schizophr Bull 2020:sbaa045. [PMID: 32221536 DOI: 10.1093/schbul/sbaa045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Read J, Williams J. Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients. Curr Drug Saf 2019;14:173-81. [PMID: 30827259 DOI: 10.2174/1574886314666190301152734] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
16 Avasthi A, Sahoo S, Grover S. Clinical Practice Guidelines for Cognitive Behavioral Therapy for Psychotic Disorders. Indian J Psychiatry 2020;62:S251-62. [PMID: 32055067 DOI: 10.4103/psychiatry.IndianJPsychiatry_774_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mehl S, Werner D, Lincoln TM. Corrigendum: Does Cognitive Behavior Therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis. Front Psychol 2019;10:1868. [PMID: 31555162 DOI: 10.3389/fpsyg.2019.01868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pyle M, Broome MR, Joyce E, MacLennan G, Norrie J, Freeman D, Fowler D, Haddad PM, Shiers D, Hollis C, Smith J, Liew A, Byrne RE, French P, Peters S, Hudson J, Davies L, Emsley R, Yung A, Birchwood M, Longden E, Morrison AP. Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS). Trials 2019;20:395. [PMID: 31272477 DOI: 10.1186/s13063-019-3506-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Hutton P, Di Rienzo F, Turkington D, Spencer H, Taylor P. Suicidal Ideation in People With Psychosis Not Taking Antipsychotic Medication: Do Negative Appraisals and Negative Metacognitive Beliefs Mediate the Effect of Symptoms? Schizophr Bull 2019;45:37-47. [PMID: 30388270 DOI: 10.1093/schbul/sby153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Bone JK, McCloud T, Scott HR, Machin K, Markham S, Persaud K, Johnson S, Lloyd-Evans B. Psychosocial Interventions to Reduce Compulsory Psychiatric Admissions: A Rapid Evidence Synthesis. EClinicalMedicine 2019;10:58-67. [PMID: 31193820 DOI: 10.1016/j.eclinm.2019.03.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 Haram A, Jonsbu E, Hole T, Fosse R. Dialogue therapy in psychosis: A philosophical-ethical approach. Nordic Psychology 2019;71:200-17. [DOI: 10.1080/19012276.2019.1586570] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Reddy LF, Horan WP, Barch DM, Buchanan RW, Gold JM, Marder SR, Wynn JK, Young J, Green MF. Understanding the Association Between Negative Symptoms and Performance on Effort-Based Decision-Making Tasks: The Importance of Defeatist Performance Beliefs. Schizophr Bull 2018;44:1217-26. [PMID: 29140501 DOI: 10.1093/schbul/sbx156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
23 Mccartney L, Douglas M, Varese F, Turkington D, Morrison AP, Dudley R. Cognitive behavioural therapy for psychosis targeting trauma, voices and dissociation: a case report. tCBT 2019;12. [DOI: 10.1017/s1754470x19000035] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Gianfrancesco O, Bubb VJ, Quinn JP. Treating the "E" in "G × E": Trauma-Informed Approaches and Psychological Therapy Interventions in Psychosis. Front Psychiatry 2019;10:9. [PMID: 30761022 DOI: 10.3389/fpsyt.2019.00009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mankiewicz PD. Cognitive Restructuring and Graded Behavioral Exposure for Persecutory Paranoia and Agoraphobic Anxiety in Complex Psychosis. Clinical Case Studies 2019;18:143-58. [DOI: 10.1177/1534650119826713] [Reference Citation Analysis]
26 Jones C, Hacker D, Xia J, Meaden A, Irving CB, Zhao S, Chen J, Shi C. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database Syst Rev 2018;12:CD007964. [PMID: 30572373 DOI: 10.1002/14651858.CD007964.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
27 Bighelli I, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, Schwermann F, Pitschel-Walz G, Barbui C, Furukawa TA, Leucht S. Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis. BMC Psychiatry 2018;18:380. [PMID: 30514268 DOI: 10.1186/s12888-018-1964-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
28 Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, Schwermann F, Pitschel-Walz G, Barbui C, Furukawa TA, Leucht S. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry 2018;17:316-29. [PMID: 30192101 DOI: 10.1002/wps.20577] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 17.5] [Reference Citation Analysis]
29 Laws KR, Darlington N, Kondel TK, McKenna PJ, Jauhar S. Cognitive Behavioural Therapy for schizophrenia - outcomes for functioning, distress and quality of life: a meta-analysis. BMC Psychol. 2018;6:32. [PMID: 30016999 DOI: 10.1186/s40359-018-0243-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
30 Correll CU, Rubio JM, Kane JM. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry 2018;17:149-60. [PMID: 29856543 DOI: 10.1002/wps.20516] [Cited by in Crossref: 128] [Cited by in F6Publishing: 102] [Article Influence: 32.0] [Reference Citation Analysis]
31 Taylor PJ, Perry A, Hutton P, Tan R, Fisher N, Focone C, Griffiths D, Seddon C. Cognitive Analytic Therapy for psychosis: A case series. Psychol Psychother 2019;92:359-78. [PMID: 29719118 DOI: 10.1111/papt.12183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
32 Rüegg N, Moritz S, Berger T, Lüdtke T, Westermann S. An internet-based intervention for people with psychosis (EviBaS): study protocol for a randomized controlled trial. BMC Psychiatry 2018;18:102. [PMID: 29653532 DOI: 10.1186/s12888-018-1644-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
33 Morrison AP, Law H, Carter L, Sellers R, Emsley R, Pyle M, French P, Shiers D, Yung AR, Murphy EK, Holden N, Steele A, Bowe SE, Palmier-Claus J, Brooks V, Byrne R, Davies L, Haddad PM. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study. Lancet Psychiatry 2018;5:411-23. [PMID: 29605187 DOI: 10.1016/S2215-0366(18)30096-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
34 Jauhar S. Cognitive behavioural therapy-a valid alternative to antipsychotics for psychosis? Lancet Psychiatry 2018;5:381-3. [PMID: 29605186 DOI: 10.1016/S2215-0366(18)30123-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
35 Klingberg S, Hesse K. [Differential indication for psychotherapy in psychosis : Are there evidence-based criteria?]. Nervenarzt 2018;89:276-82. [PMID: 29480322 DOI: 10.1007/s00115-017-0474-0] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Cooke A, Kinderman P. “But What About Real Mental Illnesses?” Alternatives to the Disease Model Approach to “Schizophrenia”. Journal of Humanistic Psychology 2018;58:47-71. [DOI: 10.1177/0022167817745621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
37 Fusar-Poli P, McGorry PD, Kane JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry 2017;16:251-65. [PMID: 28941089 DOI: 10.1002/wps.20446] [Cited by in Crossref: 251] [Cited by in F6Publishing: 227] [Article Influence: 50.2] [Reference Citation Analysis]
38 Maas DA, Vallès A, Martens GJM. Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry 2017;7:e1171. [PMID: 28934193 DOI: 10.1038/tp.2017.138] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 17.4] [Reference Citation Analysis]
39 She S, Deng Y, Chen Y, Wu C, Yi W, Lu X, Chen X, Li J, Li R, Zhang J, Xiao D, Wu H, Ning Y, Zheng Y. Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up. Psychiatry Res 2017;254:164-72. [PMID: 28463714 DOI: 10.1016/j.psychres.2017.04.054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
40 Alvarez-Jimenez M, O'Donoghue B, Thompson A, Gleeson JF, Bendall S, Gonzalez-Blanch C, Killackey E, Wunderink L, McGorry PD. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era. CNS Drugs 2016;30:357-68. [PMID: 27106296 DOI: 10.1007/s40263-016-0331-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
41 Pelsser LM, Frankena K, Toorman J, Rodrigues Pereira R. Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD. PLoS One 2017;12:e0169277. [PMID: 28121994 DOI: 10.1371/journal.pone.0169277] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 8.6] [Reference Citation Analysis]
42 Maylea CH. A rejection of involuntary treatment in mental health social work. Ethics and Social Welfare 2016;11:336-52. [DOI: 10.1080/17496535.2016.1246585] [Cited by in Crossref: 22] [Article Influence: 3.7] [Reference Citation Analysis]
43 García-Mieres H, Ochoa S, Salla M, López-Carrilero R, Feixas G. Understanding the paranoid psychosis of James: Use of the repertory grid technique for case conceptualization. World J Psychiatr 2016; 6(3): 381-390 [PMID: 27679779 DOI: 10.5498/wjp.v6.i3.381] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
44 Andreou C, Moritz S. Editorial: Non-pharmacological Interventions for Schizophrenia: How Much Can Be Achieved and How? Front Psychol 2016;7:1289. [PMID: 27621717 DOI: 10.3389/fpsyg.2016.01289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Pyle M, Norrie J, Schwannauer M, Kingdon D, Gumley A, Turkington D, Byrne R, Syrett S, MacLennan G, Dudley R, McLeod HJ, Griffiths H, Bowe S, Barnes TR, French P, Hutton P, Davies L, Morrison AP. Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial. BMC Psychiatry 2016;16:280. [PMID: 27496180 DOI: 10.1186/s12888-016-0983-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
46 Slater JJG, Painter G. Taking Steps: using collaborative group game design to consolidate and evaluate experiences of individual chief complaint-orientated cognitive behavioural therapy for psychosis (C-Co CBTp) in conditions of high security. tCBT 2016;9. [DOI: 10.1017/s1754470x16000064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 DeVylder JE, Koyanagi A, Unick J, Oh H, Nam B, Stickley A. Stress Sensitivity and Psychotic Experiences in 39 Low- and Middle-Income Countries. Schizophr Bull 2016;42:1353-62. [PMID: 27109925 DOI: 10.1093/schbul/sbw044] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
48 Hamm JA, Buck KD, Vohs J, Westerlund RJ, Lysaker PH. Interpersonal stance and dialogue in psychotherapy for schizophrenia: A supervisory approach. The Clinical Supervisor 2016;35:42-62. [DOI: 10.1080/07325223.2016.1140102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
49 Kendall T, Whittington CJ, Kuipers E, Johnson S, Birchwood MJ, Marshall M, Morrison AP; NICE guideline development group for CG178. NICE v. SIGN on psychosis and schizophrenia: same roots, similar guidelines, different interpretations. Br J Psychiatry 2016;208:316-9. [PMID: 27036696 DOI: 10.1192/bjp.bp.115.170324] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
50 Bunyan M, Ganeshalingam Y, Morgan E, Thompson-Boy D, Wigton R, Holloway F, Tracy DK. In-patient rehabilitation: clinical outcomes and cost implications. BJPsych Bull 2016;40:24-8. [PMID: 26958355 DOI: 10.1192/pb.bp.114.049858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
51 Butler L, Johns LC, Byrne M, Joseph C, O’donoghue E, Jolley S, Morris EM, Oliver JE. Running acceptance and commitment therapy groups for psychosis in community settings. Journal of Contextual Behavioral Science 2016;5:33-8. [DOI: 10.1016/j.jcbs.2015.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Ochoa S, López-Carrilero R. Early psychological interventions for psychosis. World J Psychiatr 2015; 5(4): 362-365 [PMID: 26740927 DOI: 10.5498/wjp.v5.i4.362] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Smailes D, Alderson-Day B, Fernyhough C, McCarthy-Jones S, Dodgson G. Tailoring Cognitive Behavioral Therapy to Subtypes of Voice-Hearing. Front Psychol 2015;6:1933. [PMID: 26733919 DOI: 10.3389/fpsyg.2015.01933] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
54 Devylder JE. Preventing Schizophrenia and Severe Mental Illness: A Grand Challenge for Social Work. Research on Social Work Practice 2016;26:449-59. [DOI: 10.1177/1049731515622687] [Cited by in Crossref: 8] [Article Influence: 1.1] [Reference Citation Analysis]
55 von Haebler D. Modifizierte, psychodynamische Behandlungstechnik und therapeutische Haltung in der Psychotherapie von Menschen mit Psychosen. Forum Psychoanal 2015;31:395-413. [DOI: 10.1007/s00451-015-0218-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
56 Mehl S, Werner D, Lincoln TM. Does Cognitive Behavior Therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis. Front Psychol 2015;6:1450. [PMID: 26500570 DOI: 10.3389/fpsyg.2015.01450] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
57 Longden E, Sampson M, Read J. Childhood adversity and psychosis: generalised or specific effects? Epidemiol Psychiatr Sci 2016;25:349-59. [PMID: 26156083 DOI: 10.1017/S204579601500044X] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
58 Balzan RP, Galletly C. Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study. Front Psychol 2015;6:967. [PMID: 26217283 DOI: 10.3389/fpsyg.2015.00967] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
59 Magliano L, Read J, Rinaldi A, Costanzo R, De Leo R, Schioppa G, Petrillo M. The Influence of Causal Explanations and Diagnostic Labeling on Psychology Students' Beliefs About Treatments, Prognosis, Dangerousness and Unpredictability in Schizophrenia. Community Ment Health J 2016;52:361-9. [PMID: 26081981 DOI: 10.1007/s10597-015-9901-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Nieman DH. New treatments for psychotic disorders. The Lancet Psychiatry 2015;2:282-3. [DOI: 10.1016/s2215-0366(15)00093-0] [Reference Citation Analysis]
61 Thomas N. What's really wrong with cognitive behavioral therapy for psychosis? Front Psychol 2015;6:323. [PMID: 25870572 DOI: 10.3389/fpsyg.2015.00323] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
62 Mander H, Kingdon D. The evolution of cognitive-behavioral therapy for psychosis. Psychol Res Behav Manag 2015;8:63-9. [PMID: 25733937 DOI: 10.2147/PRBM.S52267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Thomas N, Hayward M, Peters E, van der Gaag M, Bentall RP, Jenner J, Strauss C, Sommer IE, Johns LC, Varese F, García-Montes JM, Waters F, Dodgson G, McCarthy-Jones S. Psychological therapies for auditory hallucinations (voices): current status and key directions for future research. Schizophr Bull 2014;40 Suppl 4:S202-12. [PMID: 24936081 DOI: 10.1093/schbul/sbu037] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 16.0] [Reference Citation Analysis]
64 Schvarcz A, Bearden CE. Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research. Curr Behav Neurosci Rep 2015;2:90-101. [PMID: 26693133 DOI: 10.1007/s40473-015-0033-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. Author's reply: To PMID 25252316. Br J Psychiatry 2014;205:499-500. [PMID: 25452607 DOI: 10.1192/bjp.205.6.499a] [Reference Citation Analysis]
66 DeVylder J. Maximizing benefits and minimizing risks in the primary prevention of schizophrenia. Soc Work 2014;59:363-5. [PMID: 25365841 DOI: 10.1093/sw/swu027] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Abayomi O, Amato D, Bailey C, Bitanihirwe B, Bowen L, Burshtein S, Cullen A, Fusté M, Herrmann AP, Khodaie B, Kilian S, Lang QA, Manning EE, Massuda R, Nurjono M, Sadiq S, Sanchez-Gutierrez T, Sheinbaum T, Shivakumar V, Simon N, Spiteri-Staines A, Sirijit S, Toftdahl NG, Wadehra S, Wang Y, Wigton R, Wright S, Yagoda S, Zaytseva Y, O'Shea A, DeLisi LE. The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends. Schizophr Res 2014;159:e1-22. [PMID: 25306204 DOI: 10.1016/j.schres.2014.08.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Wearden A. Health behaviour interventions should not neglect people with serious mental health problems. Br J Health Psychol 2014;19:683-7. [PMID: 25293830 DOI: 10.1111/bjhp.12117] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Nordentoft M, Austin S. CBT for psychotic disorders: beyond meta-analyses and guidelines - it is time to implement! World Psychiatry 2014;13:260-1. [PMID: 25273297 DOI: 10.1002/wps.20164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
70 Thase ME, Kingdon D, Turkington D. The promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments. World Psychiatry 2014;13:244-50. [PMID: 25273290 DOI: 10.1002/wps.20149] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
71 Morrison AP, Dunn G, Turkington D, Pyle M, Hutton P. Cognitive therapy for patients with schizophrenia - Authors' reply. Lancet 2014;384:401-2. [PMID: 25088855 DOI: 10.1016/S0140-6736(14)61275-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Huang K. Knowledge Sharing in a Third-Party-Governed Health and Human Services Network. Public Admin Rev 2014;74:587-98. [DOI: 10.1111/puar.12222] [Cited by in Crossref: 33] [Article Influence: 4.1] [Reference Citation Analysis]
73 Howes O. Cognitive therapy: at last an alternative to antipsychotics? Lancet 2014;383:1364-6. [PMID: 24508319 DOI: 10.1016/S0140-6736(13)62569-6] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
74 McKenna P, Kingdon D. Has cognitive behavioural therapy for psychosis been oversold? BMJ 2014;348:g2295. [PMID: 24668904 DOI: 10.1136/bmj.g2295] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]